Literature DB >> 3511651

The role of calcium channel blockers in the treatment of hypertension.

A K Halperin, L X Cubeddu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511651     DOI: 10.1016/0002-8703(86)90154-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  14 in total

1.  Acute haemodynamic effects of urapidil and nifedipine in hypertensive urgencies and emergencies.

Authors:  F Späh; K D Grosser; G Thieme
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects.

Authors:  Li-Mei Zhao; Xiao-Jing He; Feng Qiu; Ya-Xin Sun; Jesse Li-Ling
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

3.  Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview.

Authors:  H Gavras
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.

Authors:  D R Robertson; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

Authors:  M R Lawrence; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 6.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 7.  Quality of life in the treatment of hypertension. The effect of calcium antagonists.

Authors:  A Fletcher; C Bulpitt
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.

Authors:  N T Fuenmayor; B M Faggin; L X Cubeddu
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Duration of protection of calcium channel blockers against exercise-induced bronchospasm: comparison of oral diltiazem and inhaled gallopamil.

Authors:  K L Massey; E Harman; L Hendeles
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.

Authors:  C Cardillo; V Musumeci; L Savi; R Guardigli; N Mores; G Folli
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.